Explore

World Health Organization Approves First Malaria Drug for Infants, Addressing Treatment Gap

World Health Organization Approves First Malaria Drug for Infants, Addressing Treatment Gap

The World Health Organization (WHO) has approved Coartem Baby, the first malaria drug specifically designed for infants. This new treatment, which comes in sweet cherry-flavored tablets that can be dissolved into liquids, including breast milk, aims to address the treatment gap for infants as small as 2kg. Previously, infants with malaria were treated with formulations intended for older children, which increased the risk of dosing errors, side effects, and toxicity. The approval is expected to help reduce the high malaria-related mortality rates among young children in Africa, where up to 18% of children under six months are infected with malaria. The drug, developed by Novartis and the Medicines for Malaria Venture (MMV), contains two antimalarial drugs, artemether and lumefantrine.

WHO Approves First Malaria Drug for Babies, Marking Public Health Milestone

WHO Approves First Malaria Drug for Babies, Marking Public Health Milestone

The World Health Organization (WHO) has approved Coartem Baby, the first malaria treatment specifically designed for infants. This approval is significant as it addresses a critical gap in malaria treatment for newborns, particularly in sub-Saharan Africa where malaria is prevalent. Coartem Baby, developed by Novartis and the Medicines for Malaria Venture, contains artemether and lumefantrine and is designed for infants as small as 2kg. The drug is a sweet cherry-flavored tablet that can be dissolved in liquids, including breast milk. The approval follows research challenging the misconception that young babies are immune to malaria due to maternal antibodies. The drug has already been introduced in Ghana, where it has been used successfully to treat infants.

Philanthropy's Role in Reshaping Global Health Governance

Philanthropy's Role in Reshaping Global Health Governance

Philanthropic organizations are increasingly influencing global health by producing data and research that shape how health problems are understood and prioritized. Large foundations like the Gates Foundation and Bloomberg Philanthropies are funding initiatives that provide metrics on health conditions and interventions. These metrics define what is considered a health problem and guide funding decisions. The Gates Foundation's Institute of Health Metrics and Evaluation (IHME) has become a dominant force in global health data, influencing the World Health Organization's agenda-setting. This shift towards data-driven philanthropy is reshaping global health governance.

Philanthropic Foundations Reshape Global Health Through Data-Driven Approaches

Philanthropic Foundations Reshape Global Health Through Data-Driven Approaches

Philanthropic organizations are increasingly influencing global health by producing data and research that shape how health problems are understood and prioritized. Large foundations like the Gates Foundation, Bloomberg Philanthropies, and the Chan Zuckerberg Initiative are major contributors to the budgets of the World Health Organization (WHO) and other global health initiatives. These organizations have invested heavily in creating metrics that define health problems and determine valuable interventions. For instance, the Gates Foundation established the Institute of Health Metrics and Evaluation (IHME) to provide evidence for health policy improvements. The IHME's Global Burden of Disease metrics have become a dominant force in global health, influencing WHO's agenda-setting. Bloomberg Philanthropies' Data for Health initiative, co-funded with the Australian government and the Gates Foundation, aims to standardize health records to improve public health outcomes.

Ghana Rejects US Health Deal Over Data Privacy Concerns, Seeks New Agreement

Ghana Rejects US Health Deal Over Data Privacy Concerns, Seeks New Agreement

Ghana has declined a proposed health agreement with the United States due to concerns over data privacy. The deal would have allowed U.S. entities access to Ghana's sensitive health data without adequate safeguards, according to Arnold Kavaarpuo, executive director of Ghana's Data Protection Commission. The agreement, part of the U.S.'s 'America First' global health funding approach, offered significant financial support to bolster Ghana's public health systems. However, the lack of governance oversight and the potential for data misuse led Ghana to reject the proposal, seeking improved conditions for a future agreement.

WHO delays pandemic treaty amid pathogen-sharing dispute

WHO delays pandemic treaty amid pathogen-sharing dispute

May 1 (Reuters) - World Health Organization member states said on Friday they had extended talks on pathogen-sharing rules, casting doubt on when a pandemic treaty adopted last year can come into effect.

U.S. Criticizes Zambia for Rejecting Health Deal Amidst Allegations of Mineral Extraction Ties

U.S. Criticizes Zambia for Rejecting Health Deal Amidst Allegations of Mineral Extraction Ties

The United States has expressed frustration over Zambia's refusal to commit to a new memorandum of understanding (MOU) concerning healthcare support. According to outgoing U.S. ambassador Michael Gonzales, the absence of a formal agreement has hindered the structured delivery of essential health interventions, including those for HIV, malaria, and epidemic preparedness. The proposed five-year agreement was intended to formalize U.S. support for Zambia's healthcare system, requiring Zambia to contribute approximately $340 million in counterpart funds. However, negotiations stalled after Zambia objected to terms perceived as incompatible with national priorities. The U.S. ambassador dismissed allegations that the U.S. was leveraging healthcare support for mineral extraction rights as 'patently false.'

Ghana becomes the latest African country to reject a US health deal, citing data sharing concerns

Ghana becomes the latest African country to reject a US health deal, citing data sharing concerns

Ghana has rejected a proposed health deal with the U.S. due to concerns over data privacy

Rats infest Gaza's tent camps, biting children and spreading disease

Rats infest Gaza's tent camps, biting children and spreading disease

By Nidal al-Mughrabi and Haseeb Alwazeer CAIRO/GAZA, April 30 (Reuters) - Rats and parasites are spreading through Gaza's tent camps for displaced Palestinians, biting children's fingers and toes as they sleep, gnawing through people's few remaining treasured possessions, and spreading disease.

FDA Launches AI-Driven Pilot for Real-Time Clinical Trials to Expedite Drug Approvals

FDA Launches AI-Driven Pilot for Real-Time Clinical Trials to Expedite Drug Approvals

The Food and Drug Administration (FDA) has announced a groundbreaking pilot program that utilizes artificial intelligence (AI) and cloud computing to monitor clinical trial data in real time. This initiative aims to significantly reduce the time required for the approval of new drugs, devices, and medications. The pilot involves pharmaceutical companies AstraZeneca and Amgen, who will implement the system in their respective clinical trials. The FDA's Chief Artificial Intelligence Officer, Jeremy Walsh, emphasized that the program could potentially cut clinical trial timelines by up to 40%, without compromising safety. The FDA is also seeking public and industry input on how AI technologies can enhance efficiency and decision-making in early-phase clinical trials, with responses due by May 29.

Libyan Authorities Report Tragic Migrant Losses in Mediterranean Sea

Libyan Authorities Report Tragic Migrant Losses in Mediterranean Sea

At least 17 migrants have died and nine are missing after their boat broke down and drifted for eight days in the Mediterranean Sea, according to Libya's Red Crescent and security sources. The incident highlights the perilous journey many migrants undertake, often fleeing conflict and poverty in sub-Saharan Africa in hopes of reaching Europe. The Libyan Red Crescent, in cooperation with naval forces and the coast guard, managed to rescue seven survivors near Tobruk, close to the Egyptian border. This tragedy underscores the ongoing humanitarian crisis in the region, where Libya serves as a major transit route for migrants. The country's attorney general recently announced the sentencing of four individuals involved in human trafficking, reflecting ongoing efforts to combat such crimes.